An exciting opportunity to be involved at the cutting edge of life sciences innovation in east London. Barts Life Sciences is Barts Health NHS Trust’s and Queen Mary University of London’s programme for using research, innovation and technologies to transform health and care services. This covers a broad range of activities from discovery science, product development and testing, and the...
Barts Life Sciences CAP-AI principal investigator Dr Samantha Gordon talks about the importance of including every race in artificial intelligence projects in the first video of this exciting new series by London & Partners, London’s business growth and destination agency: https://www.linkedin.com/posts/london-%26-partners_london-health-innovation-through-diversity-activity-6871410217381318656-q0Z3
About the programme Overview Run by Health Data Research UK (HDR UK) and the UK Health Data Research Alliance (the ‘Alliance’) in partnership with 10,000 Black Interns initiative, our Health Data Science Black Internship Programme provides an exciting new endeavour for early career Black data scientists who are currently heavily under-represented within the health data science. Our Health Data Science Black Internship Programme is just...
An exciting opportunity for a healthcare data scientist – the post holder will support cross regional data analysis for a project which is enabling regional, acute hospital admissions data to support vaccine safety research. To enable surveillance and research on the COVID-19 vaccination programme and other rare events there is a critical need for rapid, near real time and more...
In an effort to encourage more young people to work for the NHS, Barts Life Sciences, a joint research programme led by Barts Health NHS Trust and Queen Mary University of London, have opened a new training facility for health care and life sciences in east London in partnership with Newham College. The facility – known as the Barts Health...
Barts Life Sciences is recruiting for a digital fellow for our programme of AI and machine learning projects, CAP-AI. This project, ThyrAI, will develop automatic interpretation of thyroid biopsy specimen slides for automated diagnosis using machine and deep learning approaches. Computer programs can then be devised for feature extraction from image data and feeding of this information to classifiers for...
Professors Claude Chelala and Louise Jones from Barts Cancer Institute, Queen Mary University of London, are part of a €21.3 million public-private research programme that will seek to use artificial intelligence (AI) to improve care for patients with prostate, breast and lung cancer. The aim of the research project, named OPTIMA (Optimal Treatment for Patients with Solid Tumours in Europe Through Artificial intelligence), is to design, develop and...
Queen Mary University of London professors Rakesh Uppal and Áine McKnight have been at the centre of a new clinical trial finding that pHOXWELL – a nasal spray developed by biotech company pHOXBIO – reduced SARS-CoV-2 infection by 63 per cent in the group given pHOXWELL compared to the group given the placebo. SARS-CoV-2 is the virus that causes Covid-19....
An exciting opportunity has arisen to work as part of our precision medicine team at Barts Life Sciences. More information and how to apply can be found here: http://jobs.bartshealth.nhs.uk/job/UK/London/London/Barts_Health_NHS_Trust/Administrative_Clerical/Administrative_Clerical-v3441257?_ts=24451 Closing date: 12th September
Thousands of diabetes patients could be spared a limb amputation thanks to ground-breaking AI technology that has helped Barts Life Sciences identify people at risk from complications. Clinicians at Barts Health NHS Trust, one of the largest trusts in the UK, say it would have taken a clinician over 100 years to review the volume of data analysed in a...
Accessibility options
Translate the page